Paediatric safety signals identified in VigiBase: Methods and results from Uppsala Monitoring Centre.
Kristina StarLovisa SandbergTomas BergvallImti ChoonaraPia Caduff-JanosaI Ralph EdwardsPublished in: Pharmacoepidemiology and drug safety (2019)
Clinically relevant signals were uncovered in VigiBase by using vigiRank applied to paediatric age groups. Further refinement of the methodology is needed to identify signals in reports with ages under 2 years and to capture signals specific to the paediatric population as a risk group.